Hoth Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -0.26%170.030.7%$1331.54m
PFEPfizer Inc. -2.20%36.490.9%$1159.91m
LLYEli Lilly & Co. -2.20%208.051.1%$1015.13m
ABBVAbbVie, Inc. -3.52%104.981.9%$715.83m
AZNAstraZeneca Plc -2.43%53.121.2%$688.91m
MRKMerck & Co., Inc. -1.82%78.790.7%$682.04m
BMYBristol-Myers Squibb Co. -2.61%62.761.0%$681.69m
ARCTArcturus Therapeutics Holdings, Inc. 7.85%70.090.0%$231.22m
NVSNovartis AG -1.87%94.150.2%$193.57m
VTRSViatris, Inc. 0.03%17.100.0%$191.90m
RPRXRoyalty Pharma Plc -0.28%52.670.2%$182.22m
GSKGlaxoSmithKline Plc -1.41%38.690.2%$160.42m
GRTSGritstone Oncology, Inc. -6.18%19.290.0%$148.09m
SNYSanofi -2.35%48.000.2%$133.90m
TAKTakeda Pharmaceutical Co., Ltd. -3.14%17.610.0%$82.06m

Company Profile

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.